Central Trust CO Abbott Laboratories Transaction History

Central Trust CO

$4.19 Billion
Q3 2024

A detailed history of Central Trust CO transactions in Abbott Laboratories stock. As of the latest transaction made, Central Trust CO holds 150,934 shares of ABT stock, worth $17.5 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares

150,934

Previous 161,017 6.26%

Holding current value

$17.5 Million

Previous $16.7 Million 2.85%

% of portfolio

0.41%

Previous 0.42%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$100.07 - $118.13 $1.01 Million - $1.19 Million	-10,083 Reduced 6.26%	150,934 $17.2 Million
Q2 2024 Aug 05, 2024	SELL	$100.73 - $112.44 $371,995 - $415,240	-3,693 Reduced 2.24%	161,017 $16.7 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $241,491 - $266,716	-2,205 Reduced 1.32%	164,710 $18.7 Million
Q4 2023 Jan 24, 2024	SELL	$90.19 - $110.4 $180,650 - $221,131	-2,003 Reduced 1.19%	166,915 $18.4 Million
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $1,624 - $1,948	17 Added 0.01%	168,918 $16.4 Million
Q2 2023 Jul 26, 2023	BUY	$100.78 - $112.29 $161,651 - $180,113	1,604 Added 0.96%	168,901 $18.4 Million
Q1 2023 Apr 19, 2023	BUY	$96.86 - $114.01 $35,063 - $41,271	362 Added 0.22%	167,297 $16.9 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $640,894 - $751,867	-6,742 Reduced 3.88%	166,935 $0
Q3 2022 Nov 17, 2022	BUY	$96.76 - $112.03 $966,729 - $1.12 Million	9,991 Added 6.1%	173,677 $16.8 Million
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $214,653 - $259,447	-2,103 Reduced 1.27%	163,686 $17.8 Million
Q1 2022 May 03, 2022	SELL	$114.02 - $139.04 $137,622 - $167,821	-1,207 Reduced 0.72%	165,789 $19.6 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $62,732 - $76,812	-543 Reduced 0.32%	166,996 $23.5 Million
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $72,912 - $80,662	-625 Reduced 0.37%	167,539 $19.8 Million
Q2 2021 Jul 23, 2021	BUY	$105.79 - $124.53 $61,463 - $72,351	581 Added 0.35%	168,164 $19.5 Million
Q1 2021 Apr 23, 2021	SELL	$108.84 - $128.23 $335,227 - $394,948	-3,080 Reduced 1.8%	167,583 $20.1 Million
Q4 2020 Jan 29, 2021	SELL	$105.0 - $114.42 $4,200 - $4,576	-40 Reduced 0.02%	170,663 $18.7 Million
Q3 2020 Oct 22, 2020	BUY	$91.64 - $111.29 $118,123 - $143,452	1,289 Added 0.76%	170,703 $18.6 Million
Q2 2020 Jul 14, 2020	BUY	$76.57 - $98.0 $70,827 - $90,650	925 Added 0.55%	169,414 $15.5 Million
Q1 2020 Apr 17, 2020	BUY	$62.82 - $91.86 $274,649 - $401,611	4,372 Added 2.66%	168,489 $13.3 Million
Q4 2019 Jan 21, 2020	SELL	$78.51 - $87.4 $109,207 - $121,573	-1,391 Reduced 0.84%	164,117 $14.3 Million
Q3 2019 Oct 28, 2019	SELL	$81.84 - $88.74 $81,676 - $88,562	-998 Reduced 0.6%	165,508 $13.8 Million
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $450,908 - $525,895	-6,187 Reduced 3.58%	166,506 $0
Q1 2019 Apr 26, 2019	SELL	$66.22 - $80.06 $122,573 - $148,191	-1,851 Reduced 1.06%	172,693 $0
Q4 2018 Jan 08, 2019	SELL	$65.56 - $74.27 $171,832 - $194,661	-2,621 Reduced 1.48%	174,544 $12.6 Million
Q3 2018 Oct 04, 2018	BUY	$60.81 - $73.36 $1.32 Million - $1.6 Million	21,769 Added 14.01%	177,165 $0
Q2 2018 Jul 09, 2018	SELL	$57.57 - $63.54 $306,560 - $338,350	-5,325 Reduced 3.31%	155,396 $0
Q1 2018 Apr 04, 2018	SELL	$56.27 - $63.62 $129,646 - $146,580	-2,304 Reduced 1.41%	160,721 $0
Q4 2017 Jan 23, 2018	SELL	$53.68 - $57.47 $212,519 - $227,523	-3,959 Reduced 2.37%	163,025 $0
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $8.03 Million - $8.96 Million	166,984	166,984 $0

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Central Trust CO with notifications on news.

Account